Raphael Pharmaceutical (RAPH) Profit After Tax Growth (3y) (2023 - 2024)

Raphael Pharmaceutical (RAPH) Profit After Tax Growth (3y) (2023 - 2024) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	PAT Growth (3y) (Qtr)
1	Haleon	43.91 Bn	42.95 Bn	-	-
2	Teva Pharmaceutical Industries	43.15 Bn	39.49 Bn	2.15 Bn	14.01%
3	Zoetis	31.52 Bn	29.84 Bn	1.05 Bn	-0.23%
4	Takeda Pharmaceutical	28.58 Bn	22.78 Bn	5.10 Bn	2.89%
5	United Therapeutics	22.16 Bn	19.50 Bn	683.80 Mn	8.71%
6	Viatris	18.76 Bn	17.87 Bn	1.46 Bn	-34.81%
7	Neurocrine Biosciences	15.48 Bn	15.09 Bn	935.80 Mn	15.37%
8	Elanco Animal Health	11.69 Bn	11.16 Bn	798.00 Mn	36.74%
9	Dr Reddys Laboratories	10.13 Bn	9.96 Bn	-	-
10	Raphael Pharmaceutical	28.25 Mn	28.25 Mn	-	18.83%

Download Data